Using Dabigatran in Patients With Stroke A Practical Guide for Clinicians

被引:30
作者
Alberts, Mark J. [1 ]
Bernstein, Richard A. [1 ]
Naccarelli, Gerald V. [2 ]
Garcia, David A. [3 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Penn State Heart & Vasc Inst, Hershey, PA USA
[3] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
关键词
antithrombotics; prevention; therapy; thrombosis; DIRECT THROMBIN INHIBITOR; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; ATRIAL-FIBRILLATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; HEMORRHAGIC TRANSFORMATION; TASK-FORCE; WARFARIN; RISK; THERAPY;
D O I
10.1161/STROKEAHA.111.622498
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:271 / 279
页数:9
相关论文
共 50 条
  • [21] Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
    Huisman, Menno V.
    Lip, Gregory Y. H.
    Diener, Hans-Christoph
    Brueckmann, Martina
    van Ryn, Joanne
    Clemens, Andreas
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (05) : 838 - 847
  • [22] Economic evaluation of dabigatran for stroke prevention in patients with non-valvular atrial fibrillation
    Miguel, Luis Silva
    Rocha, Evangelista
    Ferreira, Jorge
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (7-8) : 557 - 565
  • [23] DABIGATRAN ETEXILATE: MANAGEMENT IN ACUTE ISCHEMIC STROKE
    Javedani, Parisa P.
    Horowitz, B. Zane
    Clark, Wayne M.
    Lutsep, Helmi L.
    AMERICAN JOURNAL OF CRITICAL CARE, 2013, 22 (02) : 169 - 176
  • [24] Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran
    Weimar, Christian
    Hohnloser, Stefan H.
    Eikelboom, John W.
    Diener, Hans-Christoph
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (01) : 17 - 23
  • [25] Management of bone health in patients with celiac disease Practical guide for clinicians
    Duerksen, Donald
    Pinto-Sanchez, Maria Ines
    Anca, Alexandra
    Schnetzler, Joyce
    Case, Shelley
    Zelin, Jenni
    Smallwood, Adrianna
    Turner, Justine
    Verdu, Elena
    Butzner, J. Decker
    Rashid, Mohsin
    CANADIAN FAMILY PHYSICIAN, 2018, 64 (06) : 433 - 438
  • [26] Early initiation of direct anticoagulation after stroke in patients with atrial fibrillation
    D'Anna, L.
    Filippidis, F. T.
    Antony, S.
    Brown, Z.
    Wyatt, H.
    Malik, A.
    Sivakumaran, P.
    Harvey, K.
    Marinescu, M.
    Bentley, P.
    Korompoki, E.
    Veltkamp, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (11) : 2168 - 2175
  • [27] Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation
    Wang, Ye
    Xie, Feng
    Kong, Ming Chai
    Lee, Lai Heng
    Ng, Heng Joo
    Ko, Yu
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (06) : 575 - 585
  • [28] Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding
    Van der Wall, Sake J.
    Lopes, Renato D.
    Aisenberg, James
    Reilly, Paul
    van Ryn, Joanne
    Glund, Stephan
    Elsaesser, Amelie
    Klok, Frederikus A.
    Pollack, Charles V., Jr.
    Huisman, Menno, V
    CIRCULATION, 2019, 139 (06) : 748 - 756
  • [29] New oral Anticoagulants for Prophylaxis of Stroke Results of an Expert Conference on practical Use in geriatric Patients
    Bahrmann, Philipp
    Harms, Fred
    Schambeck, Christian Martin
    Wehling, Martin
    Flohr, Juergen
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2016, 49 (05): : 460 - 461
  • [30] Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke
    Chang, Kay-Won
    Xian, Ying
    Zhao, Xin
    Mi, Xiaojuan
    Matsouaka, Roland
    Schwamm, Lee H.
    Shah, Shreyansh
    Lytle, Barbara L.
    Smith, Eric E.
    Bhatt, Deepak L.
    Fonarow, Gregg C.
    Hsu, Jonathan C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 321 : 88 - 94